Skip to main content
NCBI home page
Molecular and Cellular Biology logoLink to Molecular and Cellular Biology
. 1991 May;11(5):2425–2431. doi: 10.1128/mcb.11.5.2425

Aromaticity at position 37 in human epidermal growth factor is not obligatory for activity.

D A Engler 1, M R Hauser 1, J S Cook 1, S K Niyogi 1
PMCID: PMC360002  PMID: 1850095

Abstract

The third disulfide loop (amino acids 33 to 42) of human epidermal growth factor (hEGF) encompasses the region of highest amino acid conservation among all of the EGF-like family of molecules. The importance of some of these highly conserved residues for the maintenance of biological activity, especially the aromatic amino acid tyrosine at position 37, has until now been considered essential on the basis of previous studies with the EGF-like molecule transforming growth factor alpha. Variants at the Tyr-37 position of hEGF were constructed by site-directed mutagenesis. The substituting amino acids were phenylalanine, histidine, serine, alanine, aspartic acid, arginine, and glycine. The variants were tested for their ability to competitively displace native [125I]hEGF from its receptor and to stimulate the protein-tyrosine kinase activity of the receptor; the order of efficacy of substituting amino acids was Phe greater than His greater than Ser greater than Ala greater than Asp greater than Arg greater than Gly in both assays. All were effective, with no or only moderate reduction in potency, in stimulating the incorporation of [3H]thymidine into acid-insoluble material of quiescent mouse A31 cells. Only Tyr-37----Ala, Tyr-37----Arg and Tyr-37----Gly were slightly less potent in the cell assay. Thus, neither tyrosine nor another aromatic amino acid at position 37 in hEGF is essential for full biological activity.

Full text

PDF
2425

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson S. A., Todaro G. J. Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40. J Cell Physiol. 1968 Oct;72(2):141–148. doi: 10.1002/jcp.1040720208. [DOI] [PubMed] [Google Scholar]
  2. Aharonov A., Pruss R. M., Herschman H. R. Epidermal growth factor. Relationship between receptor regulation and mitogenesis in 3T3 cells. J Biol Chem. 1978 Jun 10;253(11):3970–3977. [PubMed] [Google Scholar]
  3. Akiyama T., Kadooka T., Ogawara H. Purification of the epidermal growth factor receptor by tyrosine-Sepharose affinity chromatography. Biochem Biophys Res Commun. 1985 Aug 30;131(1):442–448. doi: 10.1016/0006-291x(85)91822-4. [DOI] [PubMed] [Google Scholar]
  4. Avruch J., Wallach D. F. Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells. Biochim Biophys Acta. 1971 Apr 13;233(2):334–347. doi: 10.1016/0005-2736(71)90331-2. [DOI] [PubMed] [Google Scholar]
  5. Bidlingmeyer B. A., Cohen S. A., Tarvin T. L. Rapid analysis of amino acids using pre-column derivatization. J Chromatogr. 1984 Dec 7;336(1):93–104. doi: 10.1016/s0378-4347(00)85133-6. [DOI] [PubMed] [Google Scholar]
  6. Carpenter G., Cohen S. Epidermal growth factor. Annu Rev Biochem. 1979;48:193–216. doi: 10.1146/annurev.bi.48.070179.001205. [DOI] [PubMed] [Google Scholar]
  7. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem. 1987;56:881–914. doi: 10.1146/annurev.bi.56.070187.004313. [DOI] [PubMed] [Google Scholar]
  8. Cooke R. M., Wilkinson A. J., Baron M., Pastore A., Tappin M. J., Campbell I. D., Gregory H., Sheard B. The solution structure of human epidermal growth factor. 1987 May 28-Jun 3Nature. 327(6120):339–341. doi: 10.1038/327339a0. [DOI] [PubMed] [Google Scholar]
  9. Defeo-Jones D., Tai J. Y., Wegrzyn R. J., Vuocolo G. A., Baker A. E., Payne L. S., Garsky V. M., Oliff A., Riemen M. W. Structure-function analysis of synthetic and recombinant derivatives of transforming growth factor alpha. Mol Cell Biol. 1988 Aug;8(8):2999–3007. doi: 10.1128/mcb.8.8.2999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Derynck R. Transforming growth factor-alpha: structure and biological activities. J Cell Biochem. 1986;32(4):293–304. doi: 10.1002/jcb.240320406. [DOI] [PubMed] [Google Scholar]
  11. Engler D. A., Matsunami R. K., Campion S. R., Stringer C. D., Stevens A., Niyogi S. K. Cloning of authentic human epidermal growth factor as a bacterial secretory protein and its initial structure-function analysis by site-directed mutagenesis. J Biol Chem. 1988 Sep 5;263(25):12384–12390. [PubMed] [Google Scholar]
  12. Engler D. A., Montelione G. T., Niyogi S. K. Human epidermal growth factor. Distinct roles of tyrosine 37 and arginine 41 in receptor binding as determined by site-directed mutagenesis and nuclear magnetic resonance spectroscopy. FEBS Lett. 1990 Oct 1;271(1-2):47–50. doi: 10.1016/0014-5793(90)80368-s. [DOI] [PubMed] [Google Scholar]
  13. Gill G. N., Bertics P. J., Santon J. B. Epidermal growth factor and its receptor. Mol Cell Endocrinol. 1987 Jun;51(3):169–186. doi: 10.1016/0303-7207(87)90027-x. [DOI] [PubMed] [Google Scholar]
  14. Gospodarowicz D., Ill C. R., Birdwell C. R. Effects of fibroblast and epidermal growth factors on ovarian cell proliferation in vitro. I. Characterization of the response of granulosa cells to FGF and EGF. Endocrinology. 1977 Apr;100(4):1108–1120. doi: 10.1210/endo-100-4-1108. [DOI] [PubMed] [Google Scholar]
  15. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  16. Hollenberg M. D., Cuatrecasas P. Insulin and epidermal growth factor. Human fibroblast receptors related to deoxyribonucleic acid synthesis and amino acid uptake. J Biol Chem. 1975 May 25;250(10):3845–3853. [PubMed] [Google Scholar]
  17. Huang L. H., Ke X. H., Sweeney W., Tam J. P. Calcium binding and putative activity of the epidermal growth factor domain of blood coagulation factor IX. Biochem Biophys Res Commun. 1989 Apr 14;160(1):133–139. doi: 10.1016/0006-291x(89)91631-8. [DOI] [PubMed] [Google Scholar]
  18. Kohda D., Inagaki F. Complete sequence-specific 1H nuclear magnetic resonance assignments for mouse epidermal growth factor. J Biochem. 1988 Mar;103(3):554–571. doi: 10.1093/oxfordjournals.jbchem.a122307. [DOI] [PubMed] [Google Scholar]
  19. Komoriya A., Hortsch M., Meyers C., Smith M., Kanety H., Schlessinger J. Biologically active synthetic fragments of epidermal growth factor: localization of a major receptor-binding region. Proc Natl Acad Sci U S A. 1984 Mar;81(5):1351–1355. doi: 10.1073/pnas.81.5.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lazar E., Vicenzi E., Van Obberghen-Schilling E., Wolff B., Dalton S., Watanabe S., Sporn M. B. Transforming growth factor alpha: an aromatic side chain at position 38 is essential for biological activity. Mol Cell Biol. 1989 Feb;9(2):860–864. doi: 10.1128/mcb.9.2.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lin Y. Z., Caporaso G., Chang P. Y., Ke X. H., Tam J. P. Synthesis of a biological active tumor growth factor from the predicted DNA sequence of Shope fibroma virus. Biochemistry. 1988 Jul 26;27(15):5640–5645. doi: 10.1021/bi00415a037. [DOI] [PubMed] [Google Scholar]
  22. Massagué J. Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells. J Biol Chem. 1983 Nov 25;258(22):13614–13620. [PubMed] [Google Scholar]
  23. Matsunami R. K., Campion S. R., Niyogi S. K., Stevens A. Analogs of human epidermal growth factor which partially inhibit the growth factor-dependent protein-tyrosine kinase activity of the epidermal growth factor receptor. FEBS Lett. 1990 May 7;264(1):105–108. doi: 10.1016/0014-5793(90)80776-f. [DOI] [PubMed] [Google Scholar]
  24. Montelione G. T., Wüthrich K., Nice E. C., Burgess A. W., Scheraga H. A. Solution structure of murine epidermal growth factor: determination of the polypeptide backbone chain-fold by nuclear magnetic resonance and distance geometry. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5226–5230. doi: 10.1073/pnas.84.15.5226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nestor J. J., Jr, Newman S. R., DeLustro B., Todaro G. J., Schreiber A. B. A synthetic fragment of rat transforming growth factor alpha with receptor binding and antigenic properties. Biochem Biophys Res Commun. 1985 May 31;129(1):226–232. doi: 10.1016/0006-291x(85)91426-3. [DOI] [PubMed] [Google Scholar]
  26. Niyogi S. K., Foote R. S., Mural R. J., Larimer F. W., Mitra S., Soper T. S., Machanoff R., Hartman F. C. Nonessentiality of histidine 291 of Rhodospirillum rubrum ribulose-bisphosphate carboxylase/oxygenase as determined by site-directed mutagenesis. J Biol Chem. 1986 Aug 5;261(22):10087–10092. [PubMed] [Google Scholar]
  27. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Savage C. R., Jr, Hash J. H., Cohen S. Epidermal growth factor. Location of disulfide bonds. J Biol Chem. 1973 Nov 25;248(22):7669–7672. [PubMed] [Google Scholar]
  29. Selander M., Persson E., Stenflo J., Drakenberg T. 1H NMR assignment and secondary structure of the Ca2(+)-free form of the amino-terminal epidermal growth factor like domain in coagulation factor X. Biochemistry. 1990 Sep 4;29(35):8111–8118. doi: 10.1021/bi00487a018. [DOI] [PubMed] [Google Scholar]
  30. Shoyab M., Plowman G. D., McDonald V. L., Bradley J. G., Todaro G. J. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science. 1989 Feb 24;243(4894 Pt 1):1074–1076. doi: 10.1126/science.2466334. [DOI] [PubMed] [Google Scholar]
  31. Sinha N. D., Biernat J., McManus J., Köster H. Polymer support oligonucleotide synthesis XVIII: use of beta-cyanoethyl-N,N-dialkylamino-/N-morpholino phosphoramidite of deoxynucleosides for the synthesis of DNA fragments simplifying deprotection and isolation of the final product. Nucleic Acids Res. 1984 Jun 11;12(11):4539–4557. doi: 10.1093/nar/12.11.4539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stroobant P., Rice A. P., Gullick W. J., Cheng D. J., Kerr I. M., Waterfield M. D. Purification and characterization of vaccinia virus growth factor. Cell. 1985 Aug;42(1):383–393. doi: 10.1016/s0092-8674(85)80133-1. [DOI] [PubMed] [Google Scholar]
  33. Upton C., Macen J. L., McFadden G. Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha. J Virol. 1987 Apr;61(4):1271–1275. doi: 10.1128/jvi.61.4.1271-1275.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Vlodavsky I., Brown K. D., Gospodarowicz D. A comparison of the binding of epidermal growth factor to cultured granulosa and luteal cells. J Biol Chem. 1978 May 25;253(10):3744–3750. [PubMed] [Google Scholar]
  35. Wiley H. S., Walsh B. J., Lund K. A. Global modulation of the epidermal growth factor receptor is triggered by occupancy of only a few receptors. Evidence for a binary regulatory system in normal human fibroblasts. J Biol Chem. 1989 Nov 15;264(32):18912–18920. [PubMed] [Google Scholar]
  36. Winkler M. E., Bringman T., Marks B. J. The purification of fully active recombinant transforming growth factor alpha produced in Escherichia coli. J Biol Chem. 1986 Oct 15;261(29):13838–13843. [PubMed] [Google Scholar]
  37. Zoller M. J., Smith M. Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors. Methods Enzymol. 1983;100:468–500. doi: 10.1016/0076-6879(83)00074-9. [DOI] [PubMed] [Google Scholar]

Articles from Molecular and Cellular Biology are provided here courtesy of Taylor & Francis

RESOURCES